Feel Old Yet? You Can Now Emulate PS3 Games on Android Phones
Do you reminisce about games like The Last of Us, God of War III or Uncharted 2? An ad-free PS3 emulator for Android, called aPS3e, is now available on the Google Play Store.
The good news is it's free, though there's a $5 paid version if you'd like to support the developer, which doesn't give you any extra features.
The bad news: it's pretty unlikely you'll be able to revisit your PS3 favorites on a 5-year-old Android smartphone. You'll need to meet sky-high performance requirements to run the most popular PS3 games, well out of reach for average smartphone users.
The developer recommends an absolute bare minimum of 6GB of RAM, with 8GB recommended. You'll also need to be running Android 7 and up and have a high-end chip like the Snapdragon 8 Gen 1+. So, there's a good chance you'll need a relatively high-end device like the Samsung Galaxy S25 Ultra or the gaming-focused Asus ROG Phone 9 to get it to work optimally.
Users on Reddit are also reporting slow load times and plenty of bugs, though that's fairly understandable given how ambitious the project is. Previous interviews with developers from the project have noted how the PS3's unique software architecture has made emulation, particularly on Android, a difficult task. But these requirements don't seem to be putting off gamers, it has clocked up over 50,000 downloads since launching just a few days ago.
Enthusiasts have been releasing PS3 emulators since the early 2010s, though this is the first time something like this has appeared for smartphones. The app comes from a little-known Chinese developer called Aenu and is based on the RPCS3 source code, originally developed for the most popular PS3 emulator for desktop computers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
BlinkRx Launches "Operation Access Now" to Accelerate and Scale Direct‑to‑Patient and Direct‑to‑Business Programs
Operation Access Now enables pharmaceutical manufacturers to launch direct‑to‑patient programs within 21 days NEW YORK, August 07, 2025--(BUSINESS WIRE)--BlinkRx, the nation's leading prescription lifecycle management platform, today announced the launch of Operation Access Now, a rapid deployment initiative that enables pharmaceutical manufacturers to build and launch direct-to-patient (DTP) and direct‑to‑business (DTB) channels that expand medication access and deliver pricing transparency in as little as 21 days. This program comes at a moment of growing urgency across the life sciences industry. As traditional access models struggle to meet patient and provider expectations, leading brands are turning to faster, more scalable approaches. BlinkRx's national infrastructure already supports millions of patients across all 50 states. The platform's patient-centric design removes every barrier for patients to start and stay on therapy and delivers significant lift for brands: on average, 52% more patient starts and 41% more fills per patient. With Operation Access Now, the initiative enables: Rapid Stand‑Up: DTP programs that can be operational in as little as 21 days, thanks to BlinkRx's turnkey platform and flexible rules engine. Future-Proof: A modular platform that allows pharmaceutical manufacturers to start with a DTP solution and expand into future capabilities as needs and regulations change. For example, the platform can be deployed for DTB models, and can service both cashpay and insurance patients. Scale: Unique automation capabilities that enable pharmaceutical manufacturers to effortlessly scale based on patient demand and adoption. Legacy DTP solutions, such as copay cards and standalone cash pharmacies, are often costly, inefficient, and prone to patient and physician frustration- causing delays in access, misuse, and poor experiences. BlinkRx's platform addresses these ecosystem issues while ensuring strict regulatory compliance. "Operation Access Now is about removing every barrier between manufacturers and the patients who need their therapies," said Geoffrey Chaiken, Co‑Founder and CEO of BlinkRx. "We're prepared to enable manufacturers to deploy DTP programs and deliver the speed, scale, and flexibility the market demands." About BlinkRx BlinkRx is a Prescription Lifecycle Management Platform that allows the most innovative Life Sciences companies to design every aspect of the prescription journey to unlock branded medication affordability and access for all Americans. Learn more at View source version on Contacts For media inquiries, please contact: Press@
Yahoo
24 minutes ago
- Yahoo
RVN Launches Customer Portal for On-Demand Booking of Refrigerated Expedite Freight
Knoxville, Tennessee--(Newsfile Corp. - August 7, 2025) - Reefer Van Network (RVN), the leading expedite partner for the cold chain, has launched its new Customer Portal, giving shippers instant, self-serve access to book dry and temperature-controlled cargo vans and small trucks—on demand, 24/7. Reefer Van Network To view an enhanced version of this graphic, please visit: This launch marks a major step forward in RVN's mission to modernize cold chain logistics. The new portal is designed for speed, ease of use, and accessibility, empowering users to secure the right-sized equipment without waiting for callbacks, wading through quotes, or dealing with unreliable carriers. For businesses moving time and temperature-sensitive freight, RVN now offers a simple way to move faster and smarter. According to Alex Winston, Founder of RVN, "Businesses need fast, easy access to shipping solutions that get their freight picked up on demand, and delivered on time and on temp. Our portal gives them exactly that. It's one more step toward our goal of making cold chain freight more responsive, transparent, and dependable." RVN's platform addresses long-standing inefficiencies in the cold chain. Traditional LTL options are often too slow, unreliable, or simply unavailable when needed most. Full truckload solutions, while faster, tend to be oversized and expensive for smaller, temperature-sensitive loads. Meanwhile, the market has lacked a 24/7 on-demand solution for small refrigerated vehicles—until now. By connecting users directly to the largest network of refrigerated cargo vans and box trucks in the U.S., RVN allows businesses to move with confidence and control. The portal includes real-time shipment visibility, proactive updates, and always-on customer support, delivering the transparency and responsiveness customers need. "This isn't just a booking tool—it's a gateway to a better shipping experience," Winston added. "When timing and temperature matter most, RVN delivers." The RVN customer portal is now live at: About Reefer Van Network Reefer Van Network (RVN) is the leading platform for temperature-controlled and dry freight delivery using cargo vans, straight trucks, and box trucks. RVN makes it easy to book fast, reliable transport for frozen food, seafood, meat, ice cream, and dry goods—no delays, no guesswork. With on-demand capacity, real-time tracking, and 24/7 support, RVN eliminates the hassle of LTL and the cost of FTL. Backed by industry-best on-time rates and compliance expertise, RVN ensures every load arrives protected and on time. It's cold chain logistics—simplified. Media Contact Jonathan OldacreMarketing Directorjonathan@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
QBTS: D-Wave Quantum Stock Plunges After Q2 Earnings Miss Estimate
Aug 7 - D-Wave Quantum Inc. (NYSE:QBTS) shares dropped nearly 2% in premarket trading Thursday after the company reported a wider-than-expected second-quarter loss. Warning! GuruFocus has detected 5 Warning Signs with QBTS. The quantum computing firm posted an EPS of -$0.08, missing analyst expectations by $0.03. However, there was a silver lining, revenue came in at $3.1 million, comfortably beating Wall Street's forecast of $2.59 million. Despite the earnings miss, D-Wave's stock performance remains impressive. The stock trades around $17.58, marking a 58% gain over the past three months and an eye-popping 2,098% surge over the last year. Analyst sentiment has been mixed, with two EPS upgrades and one downgrade in the past 90 days. Investors seem to be betting on the long-term promise of quantum computing, even as the near-term results remain volatile. D-Wave's earnings story adds another layer to the broader tech earnings season, where innovation-heavy stocks are either soaring or sliding, depending on how closely they align with market expectations. Is QBTS Stock a Buy? Based on the one year price targets offered by 9 analysts, the average target price for D-Wave Quantum Inc is $20.11 with a high estimate of $30.00 and a low estimate of $12.00. The average target implies a upside of +14.40% from the current price of $17.58. This article first appeared on GuruFocus. Sign in to access your portfolio
